<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:7pt Arial, sans-serif; }
 .font1 { font:8pt Arial, sans-serif; }
 .font2 { font:9pt Arial, sans-serif; }
 .font3 { font:10pt Times New Roman, serif; }
 .font4 { font:17pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font4">J.P. Morgan</span></p>
<p><span class="font0" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font2" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font2" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font2" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font2" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p>
<p><span class="font1" style="font-weight:bold;">Table 10: Fosun’s M&amp;A Capability</span></p>
<table border="1">
<tr><td rowspan="2" style="vertical-align:top;"></td><td colspan="3" style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Recent Mergers and Acquisitions of Fosun Pharmaceutical</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Date</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Target Company</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Target Industry</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font0">(O</span></p>
<p><span class="font0">o cxi</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Jul-16</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Gland Pharma</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical Manufactrring</span></p></td></tr>
<tr><td rowspan="4" style="vertical-align:bottom;">
<p><span class="font0">m</span></p>
<p><span class="font0">o cxi</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Oct-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Mingy izhudao</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Internet Healthcare</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Feb-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Check Cap</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Novel Medical devices</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">May-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Ambrx</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical R&amp;D</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Apr-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Scanadu</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Novel Medical devices</span></p></td></tr>
<tr><td rowspan="3" style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jan-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Am eri gen</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical R&amp;D</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jan-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Genefirst</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Personalised Diagnosis</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jan-15</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Guahao.com</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Internet Healthcare</span></p></td></tr>
<tr><td rowspan="6" style="vertical-align:middle;">
<p><span class="font0">'J' o cxi</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Dec-14</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Ey re Pharmaceutical &amp;HHL</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical Manufactrring</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jul-14</span></p></td><td style="vertical-align:top;">
<p><span class="font0" style="font-weight:bold;">Mi </span><span class="font2" style="font-weight:bold;">a com Diagnostics</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Personalised Diagnostics</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jun-14</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Sinopharm Hldg Medical Invest</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Professional Services</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jun-14</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Natures Sunshine Products</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical Manufactrring</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Feb-14</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Jinzhou Ahon Pharm</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical Manufactrring</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Feb-14</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Chindex Medical</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Healthcare Services</span></p></td></tr>
<tr><td rowspan="5" style="vertical-align:middle;">
<p><span class="font0">co</span></p>
<p><span class="font0">o cxi</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Oct-13</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Foshan Chancheng Cntrl</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Healthcare Services</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">May-13</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">SD Bio Sensor Inc</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Medical Device</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Apr-13</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Chindex Medical</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Medical Device</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Apr-13</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Alma Laser</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Medical Device</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Mar-13</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Saladax</span></p></td><td style="vertical-align:top;">
<p><span class="font2" style="font-weight:bold;">Personalised Diagnostics</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font0">CM</span></p>
<p><span class="font0">o cxi</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Dec-12</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Hunan Dongting Pharm</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Pharmaceutical Manufactrring</span></p></td></tr>
</table>
<p><span class="font0">Source: Company data</span></p>
<p><span class="font3" style="font-weight:bold;">International expansion with differentiated strategies</span></p>
<p><span class="font3">Different from other China healthcare companies with a focus on the domestic market, Fosun seeks to establish an international network to facilitate integration of its global resources - manufacturing overseas, international cooperation on R&amp;D, product exports, and overseas M&amp;A. In 2013, it marked its first step of globalization by acquiring Alma Laser, a high-end aesthetic laser surgery device company in Israel, which it recently announced it will spin off in an IPO.</span></p>
<p><span class="font3">It has also become the exclusive distributor for Intuitive Surgical in China for its Da Vinci surgical robotic system in China. Since then, it has continued to explore and invest overseas (see table below). It plans to grow an international sales network to facilitate the integration of its international pharmaceutical operations through drug production overseas, international R&amp;D collaboration, cross-border R&amp;D, and product exports.</span></p>
<p><span class="font3">Several Fosun production lines have already obtained certifications from the US FDA, EU EDQM, and WHO PO. Moreover, the company has several ANDAs pending with the US FDA, such as felodipine long-acting sustained release tablets to treat hypertension, and glipizide controlled release tablet for diabetes. We believe such international footprint offers Fosun distinct advantage, higher entry barriers &amp;&nbsp;divarication of its healthcare platform. Up to now 13 of Fosun’s APIs have received GMP certifications from national health departments of developed nations like the US, EU and Japan.</span></p>
<p><span class="font2" style="font-weight:bold;">15</span></p>
</body>
</html>